Literature DB >> 8693066

Measurements of relative biological effectiveness of the 70 MeV proton beam at TRIUMF using Chinese hamster V79 cells and the high-precision cell sorter assay.

B G Wouters1, G K Lam, U Oelfke, K Gardey, R E Durand, L D Skarsgard.   

Abstract

Measurements of relative biological effectiveness (RBE) have been made on the range-modulated 70 MeV proton beam at TRIUMF using a precise cell sorting survival assay. In this study, Chinese hamster V79-WNRE cells were suspended in medium containing liquid gelatin at 37 degrees C in irradiation tubes and the gel was allowed to solidify by cooling to 4 degrees C. Complete cell survival responses were measured at 11 positions with 2 mm spacing within a proton stopping peak width of approximately 2 cm. Survival responses after proton irradiation were compared with responses to 60Co gamma rays measured at the same time, and RBE values were determined as a function of both dose and depth. Above doses of 4 Gy, the average RBE for these cells throughout the modulated proton stopping distribution was 1.21 +/- 0.05, measured at a survival of 1%. However, we also observed that, within the spread-out Bragg peak, the RBE increased with increasing depth, from approximately 1.2 at the proximal part to > 1.3 at the distal part of the peak. At the distal edge of the stopping distribution, the RBE value increased significantly, to an extent that may be of concern when this region of the treatment volume is close to sensitive tissues. Below 4 Gy, the RBE value was also dependent on radiation dose, increasing significantly to values of approximately 1.37 and 1.56 at 2 and 1 Gy, respectively. Our results illustrate that the use of a single RBE value in different irradiation protocols can be an oversimplification, and argues for the use of "proton gray doses" rather than "gamma-ray equivalent grays."

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8693066

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  16 in total

1.  Extension of TOPAS for the simulation of proton radiation effects considering molecular and cellular endpoints.

Authors:  Lisa Polster; Jan Schuemann; Ilaria Rinaldi; Lucas Burigo; Aimee L McNamara; Robert D Stewart; Andrea Attili; David J Carlson; Tatsuhiko Sato; José Ramos Méndez; Bruce Faddegon; Joseph Perl; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-06-10       Impact factor: 3.609

Review 2.  Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.

Authors:  Gyu Sang Yoo; Jeong Il Yu; Hee Chul Park
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

3.  Outcomes of Proton Beam Radiotherapy for Large Non-Peripapillary Choroidal and Ciliary Body Melanoma at TRIUMF and the BC Cancer Agency.

Authors:  Britta Weber; Katherine Paton; Roy Ma; Tom Pickles
Journal:  Ocul Oncol Pathol       Date:  2015-07-09

4.  Variations in linear energy transfer within clinical proton therapy fields and the potential for biological treatment planning.

Authors:  Clemens Grassberger; Alexei Trofimov; Anthony Lomax; Harald Paganetti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-14       Impact factor: 7.038

5.  Relative biological effectiveness in canine osteosarcoma cells irradiated with accelerated charged particles.

Authors:  Junko Maeda; Ian M Cartwright; Jeremy S Haskins; Yoshihiro Fujii; Hiroshi Fujisawa; Hirokazu Hirakawa; Mitsuru Uesaka; Hisashi Kitamura; Akira Fujimori; Douglas H Thamm; Takamitsu A Kato
Journal:  Oncol Lett       Date:  2016-06-30       Impact factor: 2.967

6.  Relative biological effectiveness of the 60-MeV therapeutic proton beam at the Institute of Nuclear Physics (IFJ PAN) in Kraków, Poland.

Authors:  Dorota Słonina; Beata Biesaga; Jan Swakoń; Damian Kabat; Leszek Grzanka; Marta Ptaszkiewicz; Urszula Sowa
Journal:  Radiat Environ Biophys       Date:  2014-07-19       Impact factor: 1.925

7.  Proton Relative Biological Effectiveness - Uncertainties and Opportunities.

Authors:  Harald Paganetti
Journal:  Int J Part Ther       Date:  2018-09-21

Review 8.  Proton therapy for non-small cell lung cancer: the road ahead.

Authors:  Eric D Brooks; Matthew S Ning; Vivek Verma; X Ronald Zhu; Joe Y Chang
Journal:  Transl Lung Cancer Res       Date:  2019-09

Review 9.  Range uncertainties in proton therapy and the role of Monte Carlo simulations.

Authors:  Harald Paganetti
Journal:  Phys Med Biol       Date:  2012-05-09       Impact factor: 3.609

10.  Dilemmas concerning dose distribution and the influence of relative biological effect in proton beam therapy of medulloblastoma.

Authors:  B Jones; P Wilson; A Nagano; J Fenwick; G McKenna
Journal:  Br J Radiol       Date:  2012-05-02       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.